ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,441,718, issued on Oct. 14, was assigned to VICORE PHARMA AB (Stockholm).
"Selective angiotensin II compounds" was invented by Nadia Nasser Petersen (Uppsala, Sweden), Anders Hallberg (Uppsala, Sweden), Mats Larhed (Uppsala, Sweden), Tomas Fex (Molndal, Sweden) and Bengt Ohlsson (Molndal, Sweden).
According to the abstract* released by the U.S. Patent & Trademark Office: "There is provided pharmaceutical compounds of formula I,wherein R1, R2, R3, R4, R5, R6, Y1, Y2, Y3, X and Z have meanings given in the description, which compounds are useful in the treatment of autoimmune and/or fibrotic diseases, including interstitial lung diseases, such as idiopathic pulmonary fibrosis and sarco...